News

Outlook Therapeutics® Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD
Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025 ISELIN, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc.
Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Roche Holding AG (OtherRHHVF) and AstraZeneca (AZN)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on United Therapeutics (UTHR – Research ...